Top Growth Trends in the Muscle Wasting Disorders Market: Insights into Market Size and Opportunities for 2025-2034
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Muscle Wasting Disorders Market?
The muscle wasting disorders market is poised for growth, driven by the increasing adoption of a sedentary lifestyle. When an individual leads a lifestyle that involves little to no physical movement or exercise, it’s known as a sedentary lifestyle. Such a lifestyle can adversely affect muscle function, leading to reduced muscle strength and endurance. This contributes to muscle wasting disorders and makes it challenging for individuals to preserve their muscle mass and function. For example, the World Health Organization, a Switzerland-based intergovernmental organization, reported in 2022 that over 80% of teenagers and 27% of adults did not meet the recommended physical activity standards set by this organization. Hence, the escalating adoption of a sedentary lifestyle is fuelling the expansion of the muscle wasting disorders market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13706&type=smp
#What is the Growth Potential of the Muscle Wasting Disorders Market, and How Will It Perform by 2034?
Over the past few years, the market for muscle wasting disorders has seen a significant upturn in size. The prediction is that it will inflate from $15.06 billion in 2024 to an estimated $17.54 billion in 2025 with a compound annual growth rate (CAGR) of 16.5%. This growth during the historical period is attributable to the escalation in aging population, heightened occurrence of chronic diseases, progress in research and development, heightened awareness of early diagnosis, and the emergence of new therapeutic methods.
In the coming years, the market size for muscle wasting disorders is projected to experience a substantial expansion. The market is anticipated to reach $29.67 billion by 2029, with a compound annual growth rate (CAGR) of 14.1%. The growth anticipated during the forecast period can be credited to several factors including regulatory assistance, initiatives advocating for patients, the development of healthcare infrastructure, the globalization of clinical trials, and personalized medicine strategies. Key trends in the forecast period consist of the adoption of telemedicine, technological advancements in diagnoses, innovation in products, collaborations and partnerships, advancements in therapies, molecular mechanisms research, as well as innovation in biopharmaceuticals.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13706
What Are the Key Market Innovations in theMuscle Wasting Disorders Market Over the Coming Years?
Leading firms in the muscle wasting disorders market are pioneering new products, such as groundbreaking gene therapy, to improve treatment options for patients afflicted with muscle wasting disorders. Groundbreaking gene therapy is a medical technique designed to generate curative effects by modifying gene expression or changing the biological traits of live cells. For instance, in June 2023, Sarepta Therapeutics, an American biotech company, launched Elevidys. This represents the first-ever gene therapy endorsed by the U.S. Food and Drug Administration (FDA) for managing Duchenne muscular dystrophy (DMD) in young patients aged between 4 and 5 years old. Elevidys is a type of gene therapy that introduces a gene resulting in a truncated protein containing specific domains of the normal muscle cell’s dystrophin protein into the body. The therapy is given as a one-time intravenous infusion.
Who Are the Top Companies Driving Innovation and Growth in theMuscle Wasting Disorders Market?
Major companies operating in the muscle wasting disorders market report are Pfizer Inc., F. Hoffmann-La Roche Ltd., Roche Holding AG, Novartis AG, Sanofi, GlaxoSmithKline (GSK), Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals, Acceleron Pharma Inc., Biogen Inc., Santhera Pharmaceuticals Holding AG, Mitsubishi Tanabe Pharma, Nippon Shinyaku Co. Ltd. (NS Pharma, Inc.), Sarepta Therapeutics Inc., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Axogen, Inc., FibroGen Inc., Cytokinetics Incorporated, Italfarmaco S.p.A., Scholar Rock, Bellerophon Therapeutics, Akashi Therapeutics, aTyr Pharma, Metabolic Solutions Development Company, Synaptogenix, MyoKardia, Inc., MyoTherix Inc.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/muscle-wasting-disorders-global-market-report
Which Key Market Segments Comprise the Muscle Wasting Disorders Market and Drive Its Revenue Growth?
The muscle wasting disorders market covered in this report is segmented –
1) By Treatment Type: Medications, Physical Therapy, Nutritional Therapy, Surgery, Gene Therapy, Other Treatment Types
2) By Disorder Type: Muscular Dystrophy, Amyotrophic Lateral Sclerosis (ALS), Other Disorder Types
3) By End-User: Hospitals, Rehab Centers, Specialty Clinics, Other End-Users
Subsegments:
1) By Medications: Anabolic Steroids, Hormonal Treatments, Anti-Inflammatory Drugs, Immunomodulatory Agents
2) By Physical Therapy: Resistance Training, Stretching Exercises, Aerobic Conditioning, Rehabilitation Programs
3) By Nutritional Therapy: Protein Supplements, Nutritional Counseling, Dietary Modifications, Micronutrient Supplements
4) By Surgery: Surgical Interventions For Muscle Repair, Orthopedic Surgeries, Procedures For Underlying Conditions
5) By Gene Therapy: Gene Replacement Therapy, CRISPR-Based Approaches, RNA Interference Techniques
6) By Other Treatment Types: Complementary Therapies, Psychological Support, Assistive Devices
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=13706&type=smp
Which Regions Are Emerging as Leaders in the Muscle Wasting Disorders Market?
North America was the largest region in the muscle wasting disorder market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the muscle wasting disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Muscle Wasting Disorders Market 2025, By The Business Research Company:
Anorectal Disorders Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/anorectal-disorders-treatment-global-market-report
Generic Musculoskeletal Disorders Drugs Global Market Report 2024
Optic Nerve Disorders Treatment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
